A multi-method study on GPs’ perspectives on Lipoprotein(a) as an actionable cardiovascular risk factor

1

Elevated Lipoprotein(a) [Lp(a)] is a significant risk factor for cardiovascular disease but remains underdiagnosed globally.
2

Only 2 out of 18 participating general practitioners routinely tested for Lp(a) in high cardiovascular risk patients.
3

Barriers to Lp(a) testing include lack of management pathways, costs, low public awareness, and knowledge gaps among healthcare providers.
4

The LILAC-for-Lp(a) educational framework significantly improved GPs' confidence and perspectives on managing elevated Lp(a) (p < 0.001).
5

The study highlights the need for improved training and national implementation programs to enhance Lp(a) testing and management.

Frontiers In Medicine

by Wann Jia Loh, Linh Thai, Yufan Yang, Jonathan Yeo, Bik Ling Poon, Andy Wong, Roy K. L. Teow, Elaine Lum
June 12, 2026

1